Xiaoli Zheng, MD Headshot

Xiaoli Zheng, MD

The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Beijing, Beijing

Xiaoli Zheng, MD, Associate Chief Physician of Radiation Oncology



My research focuses on basic and clinical studies of esophageal cancer and lung cancer.

Disclosures:

  • Employment: none
  • Compensation: :Role Topic Description-End Date:
  • Ownership: none
  • Leadership: none

Presentations

Sep 27

2028 - Comparative Efficacy of Whole-Brain Radiotherapy Combined with EGFR-TKI vs. EGFR-TKI Monotherapy in EGFR-Mutant NSCLC with Leptomeningeal Metastasis
Poster Hall - Exhibit Hall A
03:00pm - 04:00pm ET
Sep 27

2069 - Four-year Outcomes of Neoadjuvant Chemoimmunotherapy vs. Chemoradiotherapy in Resectable Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Study
Poster Hall - Exhibit Hall A
03:00pm - 04:00pm ET
Sep 27

2070 - Survival Outcomes of Adjuvant Immunotherapy after Neoadjuvant Chemoimmunotherapy Followed by Esophagectomy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
Poster Hall - Exhibit Hall A
03:00pm - 04:00pm ET
Sep 28

2522 - Integrating Endoscopic Clinical Priors into Deep Learning for Precise Gross Tumor Volume Delineation in Esophageal Cancer
Poster Hall - Exhibit Hall A
10:45am - 12:00pm ET
Sep 29

274 - Osimertinib Combined with Stereotactic Body Radiotherapy vs. Osimertinib Alone in Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase II Randomized Controlled Trial
Room 156
12:40pm - 12:50pm ET
Sep 29

3474 - Stereotactic Body Radiotherapy Combined with PD-1 Inhibitor in Patients with Advanced Non-Small Cell Lung Cancer: A Phase II Single-Arm Trial
Poster Hall - Exhibit Hall A
03:45pm - 05:00pm ET